PACS Group (PACS) Stock Forecast, Price Target & Predictions
PACS Stock Forecast
PACS Group (PACS) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $56.67, with a high of $62.00 and a low of $48.00. This represents a 34.64% increase from the last price of $42.09.
PACS Stock Rating
PACS Group stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
PACS Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | PACS Group | 34.64% |
| Sector | Financial Services Stocks | 7.42% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Medical Care Facilities Stocks | 15.56% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 3 | 10 |
| Avg Price Target | $62.00 | $59.67 | $49.30 |
| Last Closing Price | $42.09 | $42.09 | $42.09 |
| Upside/Downside | 47.30% | 41.77% | 17.13% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Sep, 26 | 2 | 4 | - | - | - | 6 |
| Aug, 26 | 2 | 4 | - | - | - | 6 |
| Jul, 26 | 2 | 4 | - | - | - | 6 |
| Jun, 26 | 2 | 4 | - | - | - | 6 |
| May, 26 | 2 | 4 | - | - | - | 6 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 02, 2026 | David MacDonald | Truist Financial | $62.00 | $43.00 | 44.19% | 47.30% |
| Aug 06, 2026 | UBS | $60.00 | $48.54 | 23.61% | 42.55% | |
| Jul 08, 2026 | UBS | $57.00 | $45.10 | 26.39% | 35.42% | |
| May 18, 2026 | Truist Financial | $52.00 | $37.96 | 36.99% | 23.54% | |
| May 13, 2026 | Michael Wiederhorn | Oppenheimer | $48.00 | $41.01 | 17.04% | 14.04% |
| Mar 02, 2026 | Ben Hendrix | RBC Capital | $52.00 | $37.45 | 38.85% | 23.54% |
| Dec 19, 2025 | Ben Hendrix | RBC Capital | $47.00 | $36.52 | 28.70% | 11.67% |
| Dec 18, 2025 | UBS | $42.00 | $34.68 | 21.11% | -0.21% | |
| Dec 12, 2025 | Truist Financial | $40.00 | $33.89 | 18.03% | -4.97% | |
| Nov 20, 2025 | RBC Capital | $33.00 | $25.31 | 30.38% | -21.60% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 06, 2026 | UBS | Buy | Buy | hold |
| Jul 08, 2026 | UBS | Buy | Buy | hold |
| May 13, 2026 | Oppenheimer | Outperform | Outperform | hold |
| Dec 19, 2025 | RBC Capital | Outperform | Outperform | hold |
| Nov 20, 2025 | RBC Capital | Outperform | Outperform | hold |
| Oct 09, 2024 | UBS | Buy | initialise | |
| Aug 13, 2024 | Oppenheimer | Outperform | Outperform | hold |
| Aug 13, 2024 | Stephens | Overweight | Overweight | hold |
| Aug 13, 2024 | Citigroup | Buy | Buy | hold |
| Jun 28, 2024 | Stephens | Underperform | Underperform | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | |
|---|---|---|---|---|
| Reported | $0.75 | $0.38 | - | - |
| Avg Forecast | $0.69 | $1.47 | $1.76 | $2.09 |
| High Forecast | $0.75 | $1.49 | $1.96 | $2.29 |
| Low Forecast | $0.65 | $1.45 | $1.54 | $1.82 |
| Surprise % | 8.70% | -74.15% | - | - |
Revenue Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | |
|---|---|---|---|---|
| Reported | $3.11B | $4.09B | - | - |
| Avg Forecast | $3.56B | $3.97B | $4.63B | $5.19B |
| High Forecast | $3.79B | $4.01B | $4.91B | $5.20B |
| Low Forecast | $3.41B | $3.95B | $4.41B | $5.17B |
| Surprise % | -12.57% | 3.04% | - | - |
Net Income Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | |
|---|---|---|---|---|
| Reported | $112.87M | $55.76M | - | - |
| Avg Forecast | $104.99M | $221.37M | $257.39M | $314.20M |
| High Forecast | $112.25M | $223.54M | $294.42M | $344.45M |
| Low Forecast | $97.72M | $217.03M | $231.84M | $273.01M |
| Surprise % | 7.51% | -74.81% | - | - |